Trials / Sponsors / Nordic Nanovector
Nordic Nanovector
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL Non Hodgkin Lymphoma, Follicular Lymphoma, Relapsed Follicular Lymphoma | Phase 1 | 2018-10-04 |
| Withdrawn | Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02) Non-Hodgkin Lymphoma | Phase 1 | 2017-12-19 |
| Completed | Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) Relapsed, Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 1 | 2017-03-02 |
| Completed | A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 / Phase 2 | 2012-12-01 |